Lansal, Inc. entered in a merger agreement to acquire Andover Medical, Inc. (OTCPK:ADOV) in a reverse merger transaction on April 4, 2013. As merger consideration, 91% common stock of Andover Medical will be owned by Lansal on a post-reverse split basis. Andover Medical shall pay the transaction costs from its own funds. Andover Medical has deposited $0.3 million in the escrow account. The surviving entity will operate under the name Hot Mama's Foods, Inc. Matthew Morse, Chairman of the Board, Chief Executive Officer and a Director and Joseph D. Ward, President and Chief Operating Officer of Lansal will serve in the same positions with Andover Medical. Robert Seguso, President and sole Director of Andover Medical will resign. The transaction is subject to third party consents and all approvals from governmental authorities, existing employment agreements shall all be cancelled, and the employment agreement shall be mutually agreed to and executed, stockholder approval of Andover Medical and Financial Industry Regulatory Authority approval. The transaction is expected to be completed in or about July 2013. Kenneth J. Albano of Bacon Wilson, PC acted as legal advisor for Lansal. Elliot H. Lutzker of Davidoff Hutcher & Citron LLP acted as legal advisor for Andover Medical.

Lansal, Inc. completed the acquisition of Andover Medical, Inc. (OTCPK:ADOV) in a reverse merger transaction on July 26, 2013.